Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bryostatin 8
- Development stage
- Unknown
- Lead developer
- Synaptogenix
- Modality
- Small Molecules
01
Overview
Bryostatin 8 is a member of the **bryostatin** family, a group of macrocyclic lactones derived from the marine bryozoan Bugula neritina. Bryostatins, including bryostatin 8, are known as modulators of protein kinase C (PKC) isozymes. While bryostatin 1 is the best-studied clinically and has been investigated for the treatment of cancer, Alzheimer's disease, and other neurological disorders, bryostatin 8 shares similar structural and mechanistic features but has not been tested in clinical trials and is primarily studied in preclinical or biochemical research. The mechanism of action involves **modulation of protein kinase C**, which can lead to changes in cell signaling, apoptosis, and immune function. Bryostatin 8, like other bryostatins, is considered for its potential antineoplastic (anticancer), immunomodulatory, and neurorestorative properties.
- Other names
- bryostatin 8bryostatin8bryostatin-8
02
Targets
PKD (Protein kinase D family)TLR4 (Toll-like receptor 4)PKC (Protein kinase C family)
Beyond the preview
Go deeper on bryostatin 8.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bryostatin 8.